Introduction: First cases of a disease called coronavirus disease 2019 (CO-VID-19), caused
by a novel virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) of the …

The long-term sequelae of COVID-19 have now become more common and appreciable.
The SARS-CoV-2 virus can cause a variety of infectious and non-infectious pulmonary …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of
people worlwide and caused a pandemic that is still ongoing. The virus can cause a disease …

Coronavirus disease 2019 (COVID-19) is a threat to patients not only because of its acute
course, but also because of various complications occurring in the following period, that is …

Introduction Although the rate and severity of complications after coronavirus 2019 disease
(COVID-19) resolution is currently unknown, evidence regarding their presence is …

COVID-19 caused by severe acute respiratory syndrome coronavirus 2 has led to a
pandemic situation worldwide. However, remarkable progress has been made in evolving …

The novel coronavirus SARS-CoV-2 was first identified in Wuhan in December 2019 as
cause of the consequent novel coronavirus disease 2019 (COVID-19). The virus has since …

During the COVID-19 pandemic number of patients suffering from symptoms, decreased
work ability and the deterioration in quality of life for several weeks and even months after …

Introduction: The coronavirus disease-2019 (COVID-19) pandemic has been the most
significant event in 2020, with~ 86.8 million cases and 1.88 million deaths worldwide. It is a …

Objectives Current knowledge of the pulmonary pathology of coronavirus disease 2019
(COVID-19) is based largely on postmortem studies. In most, the interval between disease …